Cyclodextrins in Antiviral Therapeutics and Vaccines

被引:33
|
作者
Braga, Susana Santos [1 ]
Barbosa, Jessica S. [1 ,2 ]
Santos, Nadia E. [1 ]
El-Saleh, Firas [3 ]
Paz, Filipe A. Almeida [2 ]
机构
[1] Univ Aveiro, Dept Chem, LAQV REQUIMTE, P-3810193 Aveiro, Portugal
[2] Univ Aveiro, CICECO Aveiro Inst Mat, Dept Chem, P-3810193 Aveiro, Portugal
[3] Ashland Specialty Ingredients, Paul Thomas Str 56, D-40599 Dusseldorf, Germany
关键词
antiviral drugs; inclusion complexes; cyclodextrins; vaccines; HYDROXYPROPYL-BETA-CYCLODEXTRIN; SIMIAN IMMUNODEFICIENCY VIRUS; INFLUENZA-A VIRUS; SQUALANE-IN-WATER; SULFOLIPO-CYCLODEXTRIN; CHOLESTEROL DEPLETION; ORAL BIOAVAILABILITY; VAGINAL TRANSMISSION; SAQUINAVIR MESYLATE; INCLUSION COMPLEX;
D O I
10.3390/pharmaceutics13030409
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present review describes the various roles of cyclodextrins (CDs) in vaccines against viruses and in antiviral therapeutics. The first section describes the most commonly studied application of cyclodextrins-solubilisation and stabilisation of antiviral drugs; some examples also refer to their beneficial taste-masking activity. The second part of the review describes the role of cyclodextrins in antiviral vaccine development and stabilisation, where they are employed as adjuvants and cryopreserving agents. In addition, cyclodextrin-based polymers as delivery systems for mRNA are currently under development. Lastly, the use of cyclodextrins as pharmaceutical active ingredients for the treatment of viral infections is explored. This new field of application is still taking its first steps. Nevertheless, promising results from the use of cyclodextrins as agents to treat other pathologies are encouraging. We present potential applications of the results reported in the literature and highlight the products that are already available on the market.
引用
收藏
页数:24
相关论文
共 50 条
  • [1] Cyclodextrins in Antiviral Therapeutics and Vaccines (vol 13, 409, 2021)
    Braga, Susana Santos
    Barbosa, Jessica S.
    Santos, Nadia E.
    El-Saleh, Firas
    Paz, Filipe A. Almeida
    PHARMACEUTICS, 2022, 14 (03)
  • [2] Microarray profiling of antiviral antibodies for the development of diagnostics, vaccines, and therapeutics
    de Vegvar, HEN
    Robinson, WH
    CLINICAL IMMUNOLOGY, 2004, 111 (02) : 196 - 201
  • [3] Potential therapeutics and vaccines: Current progress and challenges in developing antiviral treatments or vaccines for Oropouche virus
    Vijukumar, Abhishek
    Kumar, Aryan
    Kumar, Hardik
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2025, 111 (03)
  • [4] Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines
    Shibo Jiang
    Runming Li
    Lanying Du
    Shuwen Liu
    Protein & Cell, 2010, 1 (04) : 342 - 354
  • [5] Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines
    Jiang, Shibo
    Li, Runming
    Du, Lanying
    Liu, Shuwen
    PROTEIN & CELL, 2010, 1 (04) : 342 - 354
  • [6] Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines
    Sadeghian, Issa
    Heidari, Reza
    Sadeghian, Sara
    Raee, Mohammad Javad
    Negahdaripour, Manica
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 169
  • [7] Cyclodextrins in the antiviral therapy
    Jicsinszky, Laszlo
    Martina, Katia
    Cravotto, Giancarlo
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2021, 64
  • [8] Antiviral Therapeutics
    Yang, Priscilla L.
    ACS INFECTIOUS DISEASES, 2021, 7 (06): : 1297 - 1297
  • [9] Cyclodextrins: Potential therapeutics against atherosclerosis
    Mahjoubin-Tehran, Maryam
    Kovanen, Petri T.
    Xu, Suowen
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    PHARMACOLOGY & THERAPEUTICS, 2020, 214
  • [10] PEPTIDES AS ANTIVIRAL VACCINES
    MINOR, PD
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1985, 6 (01) : 34 - 38